SCHEMBL3374780

SCHEMBL3374780

CSCCNC(=O)c1c(OS(=O)(=O)C(F)(F)F)cccc1C(=O)O

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.39
HPGD P15428 4/20 0.39
NPC1 O15118 3/20 0.39
RAB9A P51151 3/20 0.39
MAPK1 P28482 2/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
TP53 P04637 1/20 0.39
NFKB1 P19838 1/20 0.39
NFKB2 Q00653 1/20 0.39
RELA Q04206 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
DRD2 P14416 3/20 0.38
DRD3 P35462 3/20 0.38
HTR1D P28221 1/20 0.38
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
TAAR1 Q96RJ0 1/20 0.37
RXFP1 Q9HBX9 1/20 0.37
DRD4 P21917 1/20 0.35
HTR5A P47898 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3374783 0.91 MEN1 (0.40) POLBHPGDNPC1RAB9AMAPK1
SCHEMBL3376179 0.89 DRD2 (0.39) POLBHPGDNPC1RAB9AMAPK1
SCHEMBL3377448 0.87 MEN1 (0.41) POLBHPGDNPC1RAB9AMAPK1
SCHEMBL3377416 0.87 DRD2 (0.47) POLBMAPK1DRD2DRD3HTR1D
SCHEMBL3377879 0.86 MEN1 (0.39) POLBHPGDNPC1RAB9AMAPK1
SCHEMBL3378263 0.85 TSHR (0.47) HPGDSMN1; SMN2DRD2DRD3HTR1D
SCHEMBL3376132 0.82 POLB (0.43) POLBHPGDSMN1; SMN2TP53DRD2
SCHEMBL3377672 0.81 DRD2 (0.35) POLBHPGDRAB9ADRD2DRD3
SCHEMBL3377632 0.81 NPSR1 (0.37) HPGDL3MBTL1DRD2DRD3HTR1D
SCHEMBL3376184 0.81 ALDH1A1 (0.40) POLBHPGDNPC1RAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1517886-B1 NOVEL PHTHALAMIDE DERIVATIVES BAYER CROPSCIENCE AG (DE) 2010-11-10 EP disclosed
US-7132455-B2 Phthalamide derivatives BAYER CROPSCIENCE AG (DE) 2006-11-07 US disclosed
US-20060035967-A1 Novel phthalamide derivatives BAYER INTELLECTUAL PROPERTY GMBH (DE) 2006-02-16 US disclosed
EP-1517886-A1 NOVEL PHTHALAMIDE DERIVATIVES Bayer CropScience AG (DE) 2005-03-30 EP disclosed
WO-2004000796-A1 NOVEL PHTHALAMIDE DERIVATIVES BAYER CROPSCIENCE AG (DE) 2003-12-31 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060035967-A1 Novel phthalamide derivatives HDAC1, HDAC2, CRY1 POLB 4159/4885HPGD 2293/4885NPC1 2506/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.